Inventurus Knowledge Solutions Grants 12,700 Employee Stock Options Under ESOP Plan 2022

1 min read     Updated on 29 Apr 2026, 06:31 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Inventurus Knowledge Solutions Limited's Nomination and Remuneration Committee has approved the grant of 12,700 employee stock options under the IKS ESOP Plan 2022 at an exercise price of Rs. 1,505.20 per option. The options are convertible into equity shares with Re. 1 face value each and comply with SEBI regulations, with comprehensive provisions for vesting, exercise, and corporate actions.

powered bylight_fuzz_icon
38906131

*this image is generated using AI for illustrative purposes only.

Inventurus Knowledge Solutions Limited's Nomination and Remuneration Committee has approved the grant of 12,700 employee stock options to eligible employees under the IKS ESOP Plan on April 28, 2026. The approval was granted pursuant to the provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

ESOP Grant Details

The employee stock options are being granted under the company's ESOP Plan 2022, which is administered through a trust. Each option granted is convertible into one fully paid-up equity share with a face value of Re. 1. The options are being granted at an exercise price of Rs. 1,505.20 per option, which is not less than the market price—the closing price on April 27, 2026, on BSE Limited being the trading day immediately preceding the date of the committee's approval.

Key ESOP Parameters

Particulars: Details
Options Granted: 12,700 employee stock options
Face Value: Re. 1 per equity share
Exercise Price: Rs. 1,505.20 per option
SEBI Compliance: SEBI (SBEB) Regulations, 2021 compliant
Total Shares Covered: 12,700 equity shares
Administration: Through Trust under IKS ESOP Plan

Vesting and Exercise Framework

The stock options granted shall be capable of being exercised anytime during the entire period of continuous active employment from the date of vesting of the respective options. The scheme provides comprehensive guidelines for handling stock options in various scenarios including death, permanent incapacity, resignation, termination, and retirement of employees.

Corporate Action Provisions

In case of corporate actions such as rights issue, bonus issue, split or consolidation of equity shares, merger, amalgamation, or sale of division, requisite adjustments shall be appropriately made in accordance with the IKS ESOP Plan. The equity shares allotted pursuant to the exercise of the stock options would not be subject to lock-in restrictions.

Regulatory Compliance

The disclosure has been made to both BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Sameer Chavan signed the regulatory filing on April 28, 2026.

Historical Stock Returns for Inventurus Knowledge Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+6.22%+15.96%+22.14%+5.44%+11.70%-15.61%

How might this ESOP grant impact Inventurus Knowledge Solutions' employee retention and talent acquisition strategy in the competitive knowledge services sector?

What could be the potential dilution effect on existing shareholders if all 12,700 stock options are exercised at the current grant price?

Will Inventurus likely expand its ESOP program further in 2026-2027 given the current market conditions and company growth trajectory?

Inventurus Knowledge Solutions
View Company Insights
View All News
like15
dislike

IKS Health Launches MyCareHub AI Platform at AMGA 2026 Conference, Reports Strong Performance Metrics

2 min read     Updated on 15 Apr 2026, 11:26 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Inventurus Knowledge Solutions Limited announced IKS Health's launch of MyCareHub, an agentic AI platform for patient engagement, at the 2026 AMGA Annual Conference in Las Vegas. The Epic-integrated platform uses multi-agent behavioral algorithms and advanced technologies including behavioral modeling, decision intelligence, and personalized communication systems. Implementation at OrthoNY since 2025 shows strong performance with 4.7% increase in total patient collections, 9.4% rise in patient payments per visit, and 8.25% increase in net payments per visit year-over-year.

powered bylight_fuzz_icon
37821387

*this image is generated using AI for illustrative purposes only.

Inventurus Knowledge Solutions Limited announced that its subsidiary IKS Health has launched MyCareHub, a groundbreaking agentic AI platform for patient engagement, at the 2026 American Medical Group Association (AMGA) Annual Conference held April 15-18 in Las Vegas.

Platform Features and Integration

MyCareHub represents a first-of-its-kind agentic AI self-orchestrating platform designed to transform patient engagement throughout the healthcare journey. The platform is integrated with Epic and available in the Epic Connection Hub, utilizing an active, aware and constant multi-agent behavioral algorithm to create a patient engagement operating system that is adaptive, autonomous and patient-first.

According to Mayank Pant, executive vice president of product management at IKS Health, "MyCareHub is not the patient engagement tool of yesteryear. It is a groundbreaking operating platform that is intelligence based and orchestrates interactions across the patient access lifecycle."

Technology and Capabilities

The platform incorporates several advanced technologies to deliver personalized patient experiences:

  • Behavioral modeling and longitudinal patient memory
  • Decision intelligence and orchestration logic
  • Safety guardrails and transparent autonomy controls
  • Scoring system for awareness of obligations, ability to meet them, and willingness to do so
  • Personalized channel, cadence and tone of reminders

These features work together to create a patient engagement platform that drives adherence while ensuring quality care and lowering total cost of care.

Implementation Results at OrthoNY

IKS Health implemented MyCareHub at OrthoNY, a leading orthopedic and pain management practice headquartered in the Capital Region of New York. The platform rollout in 2025 has generated measurable improvements in key financial metrics.

Performance Metric: Year-over-Year Change
Total Patient Collections: +4.7%
Patient Payments per Visit: +9.4%
Net Payments per Visit: +8.25%

Lisa O'Connell, senior director of revenue cycle management at OrthoNY, noted that "patients report that the mobile-friendly platform delivers confidence, transparency and ease, from registration to payment."

Leadership Perspective

Sachin K. Gupta, founder and global CEO of IKS Health, emphasized the platform's comprehensive approach: "By leveraging MyCareHub's agentic and predictive powers, healthcare organizations can understand their patients emotionally, clinically and financially. Our patient-first approach drives stronger engagement and creates intelligent anticipation that benefits patients, care teams and the long-term sustainability of healthcare organizations."

Company Background

IKS Health operates as a global leader in care enablement solutions, focusing on reducing administrative, clinical, and operational burdens in healthcare. The company integrates agentic AI workflows with human expertise through its Care Enablement platform to create smarter operations, better outcomes, and financially sustainable growth across the care journey.

Founded in 2006, IKS Health has received recognition from Black Book as the top provider of AI-driven RCM services, from KLAS for performance and client satisfaction, and from Google Cloud with the 2025 DORA Award for "Augmenting Human Expertise with AI." The company partners with major health systems, physician groups, and specialty practices across the United States.

Historical Stock Returns for Inventurus Knowledge Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+6.22%+15.96%+22.14%+5.44%+11.70%-15.61%

How will competing healthcare technology companies respond to MyCareHub's agentic AI approach in the patient engagement market?

What regulatory challenges might IKS Health face as healthcare AI platforms become more autonomous in patient interactions?

Will the strong financial results at OrthoNY translate to successful implementations across different medical specialties and practice sizes?

Inventurus Knowledge Solutions
View Company Insights
View All News
like17
dislike

More News on Inventurus Knowledge Solutions

1 Year Returns:+11.70%